Dimension AR IMT 110V/60HZ
Navigation Links
Dimension AR IMT 110V/60HZ
| Products | Dimension AR IMT 110V/60HZ |
| Company | Dade Behring, Inc. |
| Item | Dimension AR IMT 110V/60HZ |
| Features |
|
| Description | Dade Behring's Dimension clinical chemistry integrated systems combine the ease of use of the Flex reagent cartridge, the power of the Multiply and Quicklyte integrated multisensors and the innovation of the heterogeneous module to meet the challenges of your laboratory. Models of innovation and broad test menus, the systems can meet over 97% of your chemistry testing needs on a single workstation. |
| Info | Dade Behring, Inc. Customer Service: 1-847-267-5300 Web site: http://www.dadebehring.com |
1-866-262-8155Related medicine products :
1. Freshlook Dimensions
2. Dimension AR IMT 220V/50HZ
3. Dimension RxL Max™ Integrated Chemistry System 50/60HZ
4. Dimension RxL Max™ Integrated Chemistry System
5. Dimension Arx
6. Dimension Xpand Plus Integrated Chemistry System
7. Dimension AR IMT 220V/50HZ
8. Dimension RxL Max w/HM 50/60HZ
9. Dimension RxL Max w/o HM 50/60 HZ
10. Dimension Xpand
11. DFS Dimension Distal Radius Fixation System
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products:(Date:10/7/2008)...pansion means better access, more choices for Indi...mers, FORT WAYNE, Ind., Oct. 7 /PRNewswire/ -- Lu...ed agreement to partner with Consumers Life Insura...hcare service to consumers in,12 Indiana counties ...ew network partnership is Fort Wayne,s Lutheran,Ho...
(Date:10/7/2008)...://www.boomj.com Featuring Daily Articles on Brea...d Charities, HENDERSON, Nev., Oct. 7 /PRNewswire-...J) http://www.BOOMj.com, the leading social netw...the age of 35 today announced,its commitment to su...go: http://www.newscom.com/cgi-bin/prnh/20070131/...
(Date:10/7/2008)...e Fresh Flower Marketplace Offers More Than 20 Pin...eeds Supporting Susan G. Komen for the,Cure(R) at ... -- In an ongoing effort to raise,awareness and he... created,its Susan G. Komen for the Cure Pink Ribb...designed collection is available year-round and in...
(Date:10/7/2008)...VILLE, Ill., Oct. 7 /PRNewswire/ -- Viant, Inc. to...y the Centers for Medicare & Medicaid,Services (CM... audit,contractor in the national rollout of the M.... CMS has advised the company that contracts were,...ingency fee bidder that,satisfied CMS,s minimum te...
Breaking Medicine News(10 mins):Health News:Consumers Life Expands Healthcare Network in Northeast Indiana 2Health News:BOOMj, Inc. Joins Fight Against Breast Cancer 2Health News:BOOMj, Inc. Joins Fight Against Breast Cancer 3Health News:Breast Cancer Awareness Blooms in October With ProFlowers 2Health News:Breast Cancer Awareness Blooms in October With ProFlowers 3...shed in the January/February issue of General Dent...inical, peer-reviewed journal, says that most chil...ies since they have liberal doses of sugar in them...ontain a high level of sugar as well as low pH lev...
... study by Imperial College, London a high vegetabl...e. It makes people less likely to have high blood ...roteins from vegetable sources are better for BP t...s study is in consonance with other studied that l...
... Wai Kan and his team from University of Californi...he genes responsible for causing sickle cell anemi... from embryos leading to replacement of defective ...ed healthy genes produces non-defective healthy he...
...d avoid travelling to Turkey after seven confirmed...t Gennady Onishchenko said on Sunday // . Turkey ...u virus has jumped from poultry to people, the fir...tern Asia. "I earnestly advise Russian citizens t...
Other Medicine News:Health News:Russia warns against travel to Turkey, Iran closes border 2(Date:10/7/2008)...hort Enrolled in Stage A of Trial Assessing Regime...n and Paclitaxel -, TUSTIN, Calif., Oct. 7 /PRNew.... (Nasdaq: PPHM ), a clinical stage biopharmaceut...the treatment of cancer and,hepatitis C virus (HCV...,enrollment in the first stage of a Phase II trial...
(Date:10/6/2008)..., England, October 7 /-,Sos...4565) and Vectura,Group plc ("Vectura"; LSE: VEC),...ng the efficacy, safety and tolerability of NVA237...Respiratory Society (ERS) in Berlin,Germany. The ..., a novel,inhaled long-acting muscarinic antagonis...
(Date:10/6/2008)...wswire-USNewswire/ -- "A return to the use of,chim...s without scientific,justification," according to ... to Laboratory Animals (ATLA). "An Assessment of t...oncludes that vaccine responses in,chimpanzees are...laims of,chimpanzees, critical role and importance...
(Date:10/6/2008)...ips feature children, parents discussing clinical ... Md., Oct. 6 /PRNewswire-USNewswire/ -- From asthm...hildren saves lives and improves their,health and ...tutes of,Health (NIH), "Children and Clinical Stud....nih.gov ), offers parents and health,care provide...
Breaking Medicine Technology:Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4Soaking Potatoes Before Frying Cuts Suspected Carcinogen 13637 1Soaking Potatoes Before Frying Cuts Suspected Carcinogen 13637 2Dallas Dentist Trains Navy Dentists on New Therapy to Treat Snoring and Obstructive Sleep Apnea 13632 1Dallas Dentist Trains Navy Dentists on New Therapy to Treat Snoring and Obstructive Sleep Apnea 13632 2General Nutrition Centers Inc Reports Fourth Quarter and Full Year 2007 Results 13629 1General Nutrition Centers Inc Reports Fourth Quarter and Full Year 2007 Results 13629 2General Nutrition Centers Inc Reports Fourth Quarter and Full Year 2007 Results 13629 3General Nutrition Centers Inc Reports Fourth Quarter and Full Year 2007 Results 13629 4General Nutrition Centers Inc Reports Fourth Quarter and Full Year 2007 Results 13629 5General Nutrition Centers Inc Reports Fourth Quarter and Full Year 2007 Results 13629 6General Nutrition Centers Inc Reports Fourth Quarter and Full Year 2007 Results 13629 7General Nutrition Centers Inc Reports Fourth Quarter and Full Year 2007 Results 13629 8General Nutrition Centers Inc Reports Fourth Quarter and Full Year 2007 Results 13629 9General Nutrition Centers Inc Reports Fourth Quarter and Full Year 2007 Results 13629 10General Nutrition Centers Inc Reports Fourth Quarter and Full Year 2007 Results 13629 11European Union State of Brandenburg Award Grants to Alcat Europe GmbH 3753 1European Union State of Brandenburg Award Grants to Alcat Europe GmbH 3753 2[1] Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial[0] NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium[0] Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees[0] Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
...irstCall/ - AEterna,Zentaris Inc. , a global, pure...ne therapy and oncology, today announced that it,w... data on its,PI3K inhibitors as well as in vivo da... potentially provide new therapeutic,approaches fo...,presented at the American Association for Cancer ...
... 2007 - Biogen Idec Inc.,(NASDAQ: BIIB) announced ...of Managed Care Pharmacy,s (AMCP) 2007 Annual Meet...cost-effective therapy in,multiple sclerosis (MS) ... Using a comprehensive analysis of medical and pha... that patients treated,with AVONEX, the most presc...
Other Medicine Technology:AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors,and In Vivo Results for a GHRH Antagonist at the AACR Annual,Meeting in Los Angeles 2AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors,and In Vivo Results for a GHRH Antagonist at the AACR Annual,Meeting in Los Angeles 3New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective,Relative to Other Interferon Therapies for Multiple Sclerosis 2New One-Year Pharmacoeconomic Study Shows Avonex is Cost-Effective,Relative to Other Interferon Therapies for Multiple Sclerosis 3| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |